šDefinitionsĀ
Allergic Rhinitis: Inļ¬ammatory nasal condition caused by immune hypersensitivity to allergens (e.g., pollen, dust mites), characterized by:
- Sneezing, nasal congestion, rhinorrhea (clear or yellow), itchy eyes/nose.
- Symptoms typically occur within minutes of allergen exposure.
Ā
š Key Points
- Prevalence: Affects 10ā30% of children/adults in the U.S.; often persists from childhood into adulthood.
- Comorbidities: Linked to asthma (33% of patients), sinusitis, and sleep disturbances.
- Environmental controls are foundational to management.
Ā
āļø AssessmentĀ Ā
History
- Symptoms: Itching (nose/eyes), sneezing, congestion, postnasal drip, fatigue.
- Triggers: Pollen (seasonal), dust mites, pet dander (perennial).
- Red ļ¬ags: Unilateral symptoms (rule out polyps/foreign body), fever (suggests infection).
- Risk factors: Family history of atopy, young age (rare <2 years).
Examination (Telehealth Adaptations)
- Eyes: Allergic shiners (infraorbital darkening), conjunctival injection.
- Nose: Transverse crease ("allergic salute"), pale/bluish nasal mucosa.
- Throat: Cobblestoning (posterior pharynx), clear postnasal drip.
Ā
šÆ Differential DiagnosisĀ

š TreatmentĀ
Ā
- Environmental Controls
-
Outdoors: Close windows during high pollen counts; shower after exposure.
Ā
- Indoors:
- Ā
- Dust mite covers for bedding; wash linens in hot water weekly.
- Dehumidify (<50% humidity); remove carpets if possible.
-
Pet avoidance or weekly bathing (for pet allergies).
Ā
Ā
Pharmacologic Therapy
Ā
First-Line (Mild/Moderate Symptoms)
- Intranasal Corticosteroids (INS):
- Examples: Fluticasone (OTC), triamcinolone (OTC), budesonide (Rx).
-
Onset: 12ā24 hours; maximal effect in 3ā7 days.
Ā
- Second-Generation Oral Antihistamines:
- Ā
- Examples: Cetirizine (Zyrtec), loratadine (Claritin), fexofenadine (Allegra).
Ā
Add-On Therapies (Severe/Refractory Symptoms)
- Antihistamine Nasal Sprays: Azelastine (Astelin) or olopatadine (Patanase).
- Leukotriene Receptor Antagonists: Montelukast (especially if asthma coexists).
- Decongestants: Short-term use only (ā¤3 days; avoid in hypertension).
Ā
Avoid:
- First-gen antihistamines (e.g., diphenhydramine) due to sedation.
- Prolonged decongestant sprays (risk of rhinitis medicamentosa).
Ā
šØ Special Considerations
- Pregnancy: Cetirizine/loratadine (Category B) preferred.ase).
Ā
š© Referral IndicatorsĀ
- Allergy testing/immunotherapy: For perennial symptoms unresponsive to therapy.
- ENT evaluation: Unilateral symptoms, suspected structural abnormalities.
Ā
Ā š® Follow UpĀ
- Expected response: Improvement within 2 weeks.
- Preemptive therapy: Start INS 2ā4 weeks before pollen season for recurrent cases.
Ā
š Coding
ICD-10 Codes:Ā
- J30.1: Pollen-induced allergic rhinitis
- J30.81: Animal dander-induced allergic rhinitis
Ā
If you have any questions or would like more information, please reach out to the Delegating Physician.Ā

Comments (0)